Treatment of bacterial meningitis.
Major epidemiological changes have altered the empiric therapy of patients with bacterial meningitis, a disease with significant morbidity and mortality. We offer recommendations for empiric management decisions and specific antibiotic choices for patients with bacterial meningitis.
Hasbun
R
R
Department of Internal Medicine, Yale University School of Medicine, New Haven, Conn., USA.
Aronin
S I
SI
Quagliarello
V J
VJ
D000900:Anti-Bacterial Agents / Q000134:cerebrospinal fluid / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001812:Blood-Brain Barrier; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination / Q000134:cerebrospinal fluid / Q000627:therapeutic use; D006801:Humans; D015994:Incidence; D016920:Meningitis, Bacterial / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D013256:Steroids
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D013256:Steroids